HEADER TRANSFERASE 06-NOV-10 2XWY TITLE STRUCTURE OF MK-3281, A POTENT NON-NUCLEOSIDE FINGER-LOOP INHIBITOR, TITLE 2 IN COMPLEX WITH THE HEPATITIS C VIRUS NS5B POLYMERASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA-DIRECTED RNA POLYMERASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: NS5B, RESIDUES 2420-2955; COMPND 5 SYNONYM: NS5B, P68; COMPND 6 EC: 2.7.7.48; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: RESIDUES 2420-2955 OF HCV POLYPROTEIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_TAXID: 11103; SOURCE 4 STRAIN: ISOLATE BK; SOURCE 5 VARIANT: GENOTYPE 1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR: T7; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PT7.7 KEYWDS TRANSFERASE, ALLOSTERIC INHIBITOR, NUCLEOTIDYLTRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.DI MARCO,P.BAIOCCO REVDAT 3 03-APR-19 2XWY 1 REMARK REVDAT 2 26-OCT-11 2XWY 1 JRNL REMARK VERSN REVDAT 1 22-DEC-10 2XWY 0 JRNL AUTH F.NARJES,B.CRESCENZI,M.FERRARA,J.HABERMANN,S.COLARUSSO, JRNL AUTH 2 M.DEL ROSARIO RICO FERREIRA,I.STANSFIELD,A.C.MACKAY,I.CONTE, JRNL AUTH 3 C.ERCOLANI,S.ZARAMELLA,M.C.PALUMBI,P.MEULEMAN, JRNL AUTH 4 G.LEROUX-ROELS,C.GIULIANO,F.FIORE,S.DI MARCO,P.BAIOCCO, JRNL AUTH 5 U.KOCH,G.MIGLIACCIO,S.ALTAMURA,R.LAUFER,R.DE FRANCESCO, JRNL AUTH 6 M.ROWLEY JRNL TITL DISCOVERY OF (7R)-14-CYCLOHEXYL-7-{[2-(DIMETHYLAMINO)ETHYL] JRNL TITL 2 (METHYL)AMINO}-7,8-DIHYDRO-6H-INDOLO[1,2-E][1,5] JRNL TITL 3 BENZOXAZOCINE -11-CARBOXYLIC ACID (MK-3281), A POTENT AND JRNL TITL 4 ORALLY BIOAVAILABLE FINGER-LOOP INHIBITOR OF THE HEPATITIS C JRNL TITL 5 VIRUS NS5B POLYMERASE JRNL REF J.MED.CHEM. V. 54 289 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21141896 JRNL DOI 10.1021/JM1013105 REMARK 2 REMARK 2 RESOLUTION. 2.53 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.53 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 95.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 19605 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.237 REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.310 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1056 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.53 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.60 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1384 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.39 REMARK 3 BIN R VALUE (WORKING SET) : 0.3460 REMARK 3 BIN FREE R VALUE SET COUNT : 70 REMARK 3 BIN FREE R VALUE : 0.4120 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3911 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 130 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.85 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.15000 REMARK 3 B22 (A**2) : -5.32000 REMARK 3 B33 (A**2) : 4.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.679 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.366 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.350 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 34.259 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.891 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4030 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5472 ; 1.349 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 504 ; 5.734 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 160 ;33.962 ;22.875 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 675 ;18.535 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;17.260 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 622 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3000 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2529 ; 0.468 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4075 ; 0.916 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1501 ; 1.543 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1397 ; 2.504 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 534 REMARK 3 ORIGIN FOR THE GROUP (A): 24.5934 27.8694 26.8098 REMARK 3 T TENSOR REMARK 3 T11: 0.2354 T22: 0.0728 REMARK 3 T33: 0.1385 T12: -0.0467 REMARK 3 T13: -0.0874 T23: -0.0013 REMARK 3 L TENSOR REMARK 3 L11: 0.4446 L22: 1.6144 REMARK 3 L33: 0.6912 L12: -0.1955 REMARK 3 L13: -0.1715 L23: -0.1170 REMARK 3 S TENSOR REMARK 3 S11: -0.0318 S12: 0.1137 S13: -0.0610 REMARK 3 S21: -0.5880 S22: 0.0312 S23: 0.2691 REMARK 3 S31: 0.0983 S32: -0.1139 S33: 0.0006 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES WITH TLS ADDED. NO ELECTRON DENSITY WAS REMARK 3 PRESENT FOR RESIDUES 15-35, 150- 152 AND 532-536 WHICH WERE REMARK 3 THEREFORE EXCLUDED FROM THE REFINEMENT. GLN 148, PRO 149 AND HIS REMARK 3 502 HAVE BEEN MODELED AS ALA DUE TO THE LACK OF ELECTRON DENSITY REMARK 3 FOR SIDE CHAINS. REMARK 4 REMARK 4 2XWY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1290046122. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20692 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.530 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.53 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.53000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1CSJ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SOAKING WITH COMPOUND MK3281 WAS REMARK 280 PERFORMED AT 4 DEG C BY TRANSFERRING THE APO-NS5B CRYSTALS FOR REMARK 280 10 MIN IN A SOLUTION CONTAINING 100 MM 2- REMARK 280 MORPHOLINOETHANESULFONIC ACID (MES), PH 6.0, 14% POLYETHYLENE REMARK 280 GLYCOL (PEG) 8,000, 14% 2- PROPANOL, 2.5 MM TCEP, 10 MM MNCL2 REMARK 280 AND 2.5 MM OF COMPOUND MK3281. THE CRYSTALS WERE THEN REMARK 280 TRANSFERRED FOR 1 MIN TO A CRYO-PROTECTANT SOLUTION CONTAINING REMARK 280 100 MM MES PH 6.0, 14% POLYETHYLENE GLYCOL PEG 8,000, 14% 2- REMARK 280 PROPANOL, 18% 2-METHYL-2,5 PENTANEDIOL (MPD), 2.5 MM TCEP, 5 MM REMARK 280 MNCL2 AND 1.25 MM COMPOUND MK3281 AND THEN PLUNGED DIRECTLY INTO REMARK 280 LIQUID NITROGEN., TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 33.49150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.13600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.49150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.13600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 15 REMARK 465 ALA A 16 REMARK 465 GLU A 17 REMARK 465 GLU A 18 REMARK 465 SER A 19 REMARK 465 LYS A 20 REMARK 465 LEU A 21 REMARK 465 PRO A 22 REMARK 465 ILE A 23 REMARK 465 ASN A 24 REMARK 465 ALA A 25 REMARK 465 LEU A 26 REMARK 465 SER A 27 REMARK 465 ASN A 28 REMARK 465 SER A 29 REMARK 465 LEU A 30 REMARK 465 LEU A 31 REMARK 465 ARG A 32 REMARK 465 HIS A 33 REMARK 465 HIS A 34 REMARK 465 ASN A 35 REMARK 465 GLU A 150 REMARK 465 LYS A 151 REMARK 465 GLY A 152 REMARK 465 THR A 532 REMARK 465 LYS A 533 REMARK 465 LEU A 534 REMARK 465 LYS A 535 REMARK 465 LEU A 536 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 10 CG CD1 CD2 REMARK 470 CYS A 14 SG REMARK 470 THR A 41 OG1 CG2 REMARK 470 LYS A 50 CG CD CE NZ REMARK 470 GLN A 148 CG CD OE1 NE2 REMARK 470 PRO A 149 CG CD REMARK 470 ARG A 154 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 402 CG ND1 CD2 CE1 NE2 REMARK 470 HIS A 502 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 505 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 248 O HOH A 2068 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 2040 O HOH A 2040 2665 1.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 170 CB CYS A 170 SG -0.096 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 149 N - CA - CB ANGL. DEV. = 8.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 98 172.64 -55.29 REMARK 500 LYS A 100 14.39 -69.14 REMARK 500 VAL A 131 -60.92 -139.31 REMARK 500 ASN A 142 59.73 -92.51 REMARK 500 ARG A 222 109.62 -55.37 REMARK 500 CYS A 223 84.24 31.79 REMARK 500 LEU A 260 -49.29 -147.44 REMARK 500 THR A 267 118.60 -161.01 REMARK 500 ASN A 273 89.21 -59.09 REMARK 500 ASP A 310 69.96 24.77 REMARK 500 SER A 367 19.35 56.79 REMARK 500 ARG A 401 117.32 -162.90 REMARK 500 ILE A 424 -64.56 -99.77 REMARK 500 GLU A 437 12.49 56.01 REMARK 500 GLN A 438 32.48 -92.51 REMARK 500 PHE A 526 13.29 -145.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2022 DISTANCE = 7.33 ANGSTROMS REMARK 525 HOH A2043 DISTANCE = 6.13 ANGSTROMS REMARK 525 HOH A2052 DISTANCE = 8.67 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A1533 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 220 OD1 REMARK 620 2 THR A 221 O 77.9 REMARK 620 3 ASP A 318 OD2 76.5 86.4 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A1534 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 318 OD1 REMARK 620 2 HOH A2130 O 158.1 REMARK 620 3 ASP A 319 OD1 84.3 78.7 REMARK 620 4 ASP A 220 OD2 88.2 83.5 106.1 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IB8 A 1532 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 1533 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MN A 1534 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NHU RELATED DB: PDB REMARK 900 HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE REMARK 900 ANALOGUE INHIBITOR REMARK 900 RELATED ID: 2I1R RELATED DB: PDB REMARK 900 NOVEL THIAZOLONES AS HCV NS5B POLYMERASE INHIBITORS:FURTHER DESIGNS, REMARK 900 SYNTHESIS, SAR AND X-RAY COMPLEX STRUCTURE REMARK 900 RELATED ID: 1JXP RELATED DB: PDB REMARK 900 BK STRAIN HEPATITIS C VIRUS (HCV) NS3-NS4A REMARK 900 RELATED ID: 2WCX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS5B POLYMERASE IN COMPLEX REMARK 900 WITH THIENOPYRROLE- BASED FINGER-LOOP INHIBITORS REMARK 900 RELATED ID: 1GX6 RELATED DB: PDB REMARK 900 HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH UTP AND MANGANESE REMARK 900 RELATED ID: 2JC1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH REMARK 900 INHIBITOR SB698223 REMARK 900 RELATED ID: 8OHM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RIBONUCLEIC ACID HELICASE FROM GENOTYPE 1B REMARK 900 HEPATITIS C VIRUS: MECHANISM OF UNWINDING DUPLEX RIBONUCLEIC ACID REMARK 900 RELATED ID: 1C2P RELATED DB: PDB REMARK 900 HEPATITIS C VIRUS NS5B RIBONUCLEIC ACID- DEPENDENT RIBONUCLEIC ACID REMARK 900 POLYMERASE REMARK 900 RELATED ID: 1A1Q RELATED DB: PDB REMARK 900 HEPATITIS C VIRUS NS3 PROTEINASE REMARK 900 RELATED ID: 1BT7 RELATED DB: PDB REMARK 900 THE SOLUTION NMR STRUCTURE OF THE N- TERMINAL PROTEASEDOMAIN OF THE REMARK 900 HEPATITIS C VIRUS (HCV) NS3-PROTEIN, FROM BKSTRAIN, 20 STRUCTURES REMARK 900 RELATED ID: 1CU1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN ENZYME COMPLEX FROM HEPATITIS C VIRUS REMARK 900 RELATED ID: 2AX1 RELATED DB: PDB REMARK 900 HEPATITIS C VIRUS NS5B RNA POLYMERASE IN COMPLEX WITH ACOVALENT REMARK 900 INHIBITOR (5EE) REMARK 900 RELATED ID: 2JC0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH REMARK 900 INHIBITOR SB655264 REMARK 900 RELATED ID: 1NS3 RELATED DB: PDB REMARK 900 STRUCTURE OF HCV PROTEASE (BK STRAIN) REMARK 900 RELATED ID: 1NHV RELATED DB: PDB REMARK 900 HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH NON-NUCLEOSIDE REMARK 900 ANALOGUE INHIBITOR REMARK 900 RELATED ID: 1CSJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID- DEPENDENT RIBONUCLEIC REMARK 900 ACID POLYMERASE OF HEPATITIS C VIRUS REMARK 900 RELATED ID: 2WHO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS5B POLYMERASE FROM 1B REMARK 900 GENOTYPE IN COMPLEX WITH A NON-NUCLEOSIDE INHIBITOR REMARK 900 RELATED ID: 2BRL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH REMARK 900 AN ALLOSTERIC INHIBITOR (COMPOUND 2) REMARK 900 RELATED ID: 2BRK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH REMARK 900 AN ALLOSTERIC INHIBITOR (COMPOUND 1) REMARK 900 RELATED ID: 1GX5 RELATED DB: PDB REMARK 900 HEPATITIS C VIRUS RNA POLYMERASE IN COMPLEX WITH GTP AND MANGANESE REMARK 900 RELATED ID: 2AX0 RELATED DB: PDB REMARK 900 HEPATITIS C VIRUS NS5B RNA POLYMERASE IN COMPLEX WITH ACOVALENT REMARK 900 INHIBITOR (5X) REMARK 900 RELATED ID: 2AWZ RELATED DB: PDB REMARK 900 HEPATITIS C VIRUS NS5B RNA POLYMERASE IN COMPLEX WITH ACOVALENT REMARK 900 INHIBITOR (5H) REMARK 900 RELATED ID: 1QUV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE RIBONUCLEIC ACID DIRECTED RIBONUCLEIC ACID REMARK 900 POLYMERASE OF HEPATITIS C VIRUS REMARK 900 RELATED ID: 1OS5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HCV NS5B RNA POLYMERASE COMPLEXED WITHA NOVEL REMARK 900 NON-COMPETITIVE INHIBITOR. DBREF 2XWY A 1 536 UNP P26663 POLG_HCVBK 2420 2955 SEQADV 2XWY MET A 0 UNP P26663 EXPRESSION TAG SEQRES 1 A 537 MET SER MET SER TYR THR TRP THR GLY ALA LEU ILE THR SEQRES 2 A 537 PRO CYS ALA ALA GLU GLU SER LYS LEU PRO ILE ASN ALA SEQRES 3 A 537 LEU SER ASN SER LEU LEU ARG HIS HIS ASN MET VAL TYR SEQRES 4 A 537 ALA THR THR SER ARG SER ALA GLY LEU ARG GLN LYS LYS SEQRES 5 A 537 VAL THR PHE ASP ARG LEU GLN VAL LEU ASP ASP HIS TYR SEQRES 6 A 537 ARG ASP VAL LEU LYS GLU MET LYS ALA LYS ALA SER THR SEQRES 7 A 537 VAL LYS ALA LYS LEU LEU SER VAL GLU GLU ALA CYS LYS SEQRES 8 A 537 LEU THR PRO PRO HIS SER ALA LYS SER LYS PHE GLY TYR SEQRES 9 A 537 GLY ALA LYS ASP VAL ARG ASN LEU SER SER LYS ALA VAL SEQRES 10 A 537 ASN HIS ILE HIS SER VAL TRP LYS ASP LEU LEU GLU ASP SEQRES 11 A 537 THR VAL THR PRO ILE ASP THR THR ILE MET ALA LYS ASN SEQRES 12 A 537 GLU VAL PHE CYS VAL GLN PRO GLU LYS GLY GLY ARG LYS SEQRES 13 A 537 PRO ALA ARG LEU ILE VAL PHE PRO ASP LEU GLY VAL ARG SEQRES 14 A 537 VAL CYS GLU LYS MET ALA LEU TYR ASP VAL VAL SER THR SEQRES 15 A 537 LEU PRO GLN VAL VAL MET GLY SER SER TYR GLY PHE GLN SEQRES 16 A 537 TYR SER PRO GLY GLN ARG VAL GLU PHE LEU VAL ASN THR SEQRES 17 A 537 TRP LYS SER LYS LYS ASN PRO MET GLY PHE SER TYR ASP SEQRES 18 A 537 THR ARG CYS PHE ASP SER THR VAL THR GLU ASN ASP ILE SEQRES 19 A 537 ARG VAL GLU GLU SER ILE TYR GLN CYS CYS ASP LEU ALA SEQRES 20 A 537 PRO GLU ALA ARG GLN ALA ILE LYS SER LEU THR GLU ARG SEQRES 21 A 537 LEU TYR ILE GLY GLY PRO LEU THR ASN SER LYS GLY GLN SEQRES 22 A 537 ASN CYS GLY TYR ARG ARG CYS ARG ALA SER GLY VAL LEU SEQRES 23 A 537 THR THR SER CYS GLY ASN THR LEU THR CYS TYR LEU LYS SEQRES 24 A 537 ALA SER ALA ALA CYS ARG ALA ALA LYS LEU GLN ASP CYS SEQRES 25 A 537 THR MET LEU VAL ASN GLY ASP ASP LEU VAL VAL ILE CYS SEQRES 26 A 537 GLU SER ALA GLY THR GLN GLU ASP ALA ALA SER LEU ARG SEQRES 27 A 537 VAL PHE THR GLU ALA MET THR ARG TYR SER ALA PRO PRO SEQRES 28 A 537 GLY ASP PRO PRO GLN PRO GLU TYR ASP LEU GLU LEU ILE SEQRES 29 A 537 THR SER CYS SER SER ASN VAL SER VAL ALA HIS ASP ALA SEQRES 30 A 537 SER GLY LYS ARG VAL TYR TYR LEU THR ARG ASP PRO THR SEQRES 31 A 537 THR PRO LEU ALA ARG ALA ALA TRP GLU THR ALA ARG HIS SEQRES 32 A 537 THR PRO VAL ASN SER TRP LEU GLY ASN ILE ILE MET TYR SEQRES 33 A 537 ALA PRO THR LEU TRP ALA ARG MET ILE LEU MET THR HIS SEQRES 34 A 537 PHE PHE SER ILE LEU LEU ALA GLN GLU GLN LEU GLU LYS SEQRES 35 A 537 ALA LEU ASP CYS GLN ILE TYR GLY ALA CYS TYR SER ILE SEQRES 36 A 537 GLU PRO LEU ASP LEU PRO GLN ILE ILE GLU ARG LEU HIS SEQRES 37 A 537 GLY LEU SER ALA PHE SER LEU HIS SER TYR SER PRO GLY SEQRES 38 A 537 GLU ILE ASN ARG VAL ALA SER CYS LEU ARG LYS LEU GLY SEQRES 39 A 537 VAL PRO PRO LEU ARG VAL TRP ARG HIS ARG ALA ARG SER SEQRES 40 A 537 VAL ARG ALA ARG LEU LEU SER GLN GLY GLY ARG ALA ALA SEQRES 41 A 537 THR CYS GLY LYS TYR LEU PHE ASN TRP ALA VAL LYS THR SEQRES 42 A 537 LYS LEU LYS LEU HET IB8 A1532 35 HET MN A1533 1 HET MN A1534 1 HETNAM IB8 (7R)-14-CYCLOHEXYL-7-{[2-(DIMETHYLAMINO)ETHYL](METHYL) HETNAM 2 IB8 AMINO}-7,8-DIHYDRO-6H-INDOLO[1,2-E][1,5]BENZOXAZOCINE- HETNAM 3 IB8 11-CARBOXYLIC ACID HETNAM MN MANGANESE (II) ION FORMUL 2 IB8 C29 H37 N3 O3 FORMUL 3 MN 2(MN 2+) FORMUL 5 HOH *130(H2 O) HELIX 1 1 THR A 41 ARG A 43 5 3 HELIX 2 2 SER A 44 THR A 53 1 10 HELIX 3 3 ASP A 61 SER A 76 1 16 HELIX 4 4 SER A 84 LEU A 91 1 8 HELIX 5 5 GLY A 104 ASN A 110 1 7 HELIX 6 6 SER A 112 ASP A 129 1 18 HELIX 7 7 ASP A 164 SER A 180 1 17 HELIX 8 8 THR A 181 GLY A 188 1 8 HELIX 9 9 GLY A 192 TYR A 195 5 4 HELIX 10 10 SER A 196 SER A 210 1 15 HELIX 11 11 CYS A 223 VAL A 228 1 6 HELIX 12 12 THR A 229 GLN A 241 1 13 HELIX 13 13 ALA A 246 LEU A 260 1 15 HELIX 14 14 LEU A 285 LYS A 307 1 23 HELIX 15 15 GLY A 328 TYR A 346 1 19 HELIX 16 16 ASP A 359 ILE A 363 5 5 HELIX 17 17 PRO A 388 GLU A 398 1 11 HELIX 18 18 ASN A 406 TYR A 415 1 10 HELIX 19 19 THR A 418 ILE A 424 1 7 HELIX 20 20 ILE A 424 GLN A 436 1 13 HELIX 21 21 GLU A 455 LEU A 457 5 3 HELIX 22 22 ASP A 458 GLY A 468 1 11 HELIX 23 23 LEU A 469 SER A 473 5 5 HELIX 24 24 SER A 478 GLY A 493 1 16 HELIX 25 25 PRO A 496 SER A 513 1 18 HELIX 26 26 GLY A 515 LEU A 525 1 11 HELIX 27 27 PHE A 526 VAL A 530 5 5 SHEET 1 AA 5 TYR A 4 TRP A 6 0 SHEET 2 AA 5 GLY A 275 ARG A 277 -1 O TYR A 276 N THR A 5 SHEET 3 AA 5 GLY A 264 THR A 267 -1 O GLY A 264 N ARG A 277 SHEET 4 AA 5 THR A 136 ALA A 140 1 O THR A 136 N THR A 267 SHEET 5 AA 5 LEU A 159 PRO A 163 -1 O ILE A 160 N MET A 139 SHEET 1 AB 2 VAL A 37 ALA A 39 0 SHEET 2 AB 2 VAL A 144 CYS A 146 -1 O PHE A 145 N TYR A 38 SHEET 1 AC 3 PRO A 214 TYR A 219 0 SHEET 2 AC 3 ASP A 319 GLU A 325 -1 O LEU A 320 N TYR A 219 SHEET 3 AC 3 GLN A 309 ASN A 316 -1 O GLN A 309 N GLU A 325 SHEET 1 AD 2 ASN A 369 HIS A 374 0 SHEET 2 AD 2 ARG A 380 THR A 385 -1 O VAL A 381 N ALA A 373 SHEET 1 AE 2 LEU A 443 ILE A 447 0 SHEET 2 AE 2 ALA A 450 ILE A 454 -1 O ALA A 450 N ILE A 447 LINK MN MN A1533 OD1 ASP A 220 1555 1555 2.12 LINK MN MN A1533 O THR A 221 1555 1555 2.30 LINK MN MN A1533 OD2 ASP A 318 1555 1555 2.19 LINK MN MN A1534 OD1 ASP A 318 1555 1555 1.96 LINK MN MN A1534 O HOH A2130 1555 1555 2.04 LINK MN MN A1534 OD1 ASP A 319 1555 1555 2.55 LINK MN MN A1534 OD2 ASP A 220 1555 1555 2.35 SITE 1 AC1 9 VAL A 37 ALA A 395 ALA A 396 ILE A 424 SITE 2 AC1 9 HIS A 428 GLY A 493 VAL A 494 PRO A 495 SITE 3 AC1 9 ARG A 503 SITE 1 AC2 5 ASP A 220 THR A 221 ASP A 318 MN A1534 SITE 2 AC2 5 HOH A2129 SITE 1 AC3 5 ASP A 220 ASP A 318 ASP A 319 MN A1533 SITE 2 AC3 5 HOH A2130 CRYST1 66.983 94.272 95.145 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014929 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010608 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010510 0.00000 MASTER 537 0 3 27 14 0 7 6 0 0 0 42 END